Clinical trial

Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery

NCT00396760 · German Heart Center, Other · Unknown status

Key facts

NCT number NCT00396760
Title Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery
Official title The Influence of High-Dose Aprotinin and Tranexamic Acid on Bleeding Tendency and Allogeneic Blood Transfusion in Patients Undergoing Primary Aortic Valve Replacement or Coronary Artery Revascularization
Lead sponsor German Heart Center, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Bleeding and Cardiac Surgery, Allogeneic Blood Transfusion, Aortic Valve Replacement, Coronary Artery Bypass Graft Surgery
Intervention type Drug
Interventions aprotinin or tranexamic acid
Enrollment 220
Start date Jan 1, 2005
Completion Jul 1, 2006
First posted Nov 7, 2006
Last update posted Nov 7, 2006
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies